Consequently, vesicles from temozolomide-resistant glioblastoma cells spread a resistant phenotype, delivering high levels of SBF2-AS1 to sensitive cells, which in turn deregulates XRCC4 and enhances the DNA double-strand break repair process [42,148]. This evidence concerns the gene SBF2 and glioblastoma.